Related Experiment Video

Updated: Mar 31, 2026

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
10:31

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice

Published on: May 2, 2025

821

The application of multi-omics and systems biology to identify therapeutic targets in chronic kidney disease

Katryna Cisek1, Magdalena Krochmal2,3, Julie Klein4,5

  • 1Mosaiques Diagnostics GmbH, Hannover, Germany.

Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
|October 22, 2015
PubMed

Insights

Integrating omics data using systems biology offers a new approach to discovering chronic kidney disease (CKD) biomarkers and therapies. This method models molecular changes for better drug discovery and understanding disease progression.

Area of Science:

  • Biomedical Informatics
  • Systems Biology
  • Genomics and Proteomics

Background:

  • Chronic kidney disease (CKD) presents complex molecular challenges for therapeutic target discovery.
  • Advances in omics technologies generate vast datasets (genomics, proteomics, metabolomics, etc.).

Purpose of the Study:

  • To review omics data integration using systems biology for CKD biomarker and drug discovery.
  • To explore the application of systems biology in modeling molecular changes in CKD.

Main Methods:

  • Review of omics data integration concepts and systems biology principles.
  • Description of key bioinformatics databases and tools.
  • Discussion of challenges and limitations in current omics integration.

Main Results:

  • Systems biology enables comprehensive modeling of molecular changes in CKD.
  • Integration of diverse omics data can identify specific disease pathways and key events.
  • Visualization tools aid in tracking disease progression and generating clinically relevant models.

Conclusions:

  • Omics data integration via systems biology is a powerful approach for CKD research.
  • This approach facilitates the discovery of novel therapeutic targets and biomarkers.
  • Systems biology modeling enhances understanding of CKD pathogenesis and progression.
Keywords:
chronic kidney diseasedata integrationomicssystems biologytherapeutic target

Related Concept Videos

Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
625
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
84
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
1.2K
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
957
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
612
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
1.9K